Human Genetics

, Volume 132, Issue 4, pp 473–480 | Cite as

Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita

  • Bari J. Ballew
  • Meredith Yeager
  • Kevin Jacobs
  • Neelam Giri
  • Joseph Boland
  • Laurie Burdett
  • Blanche P. Alter
  • Sharon A. Savage
Original Investigation


Dyskeratosis congenita (DC) is an inherited bone marrow failure and cancer predisposition syndrome caused by aberrant telomere biology. The classic triad of dysplastic nails, abnormal skin pigmentation, and oral leukoplakia is diagnostic of DC, but substantial clinical heterogeneity exists; the clinically severe variant Hoyeraal Hreidarsson syndrome (HH) also includes cerebellar hypoplasia, severe immunodeficiency, enteropathy, and intrauterine growth retardation. Germline mutations in telomere biology genes account for approximately one-half of known DC families. Using exome sequencing, we identified mutations in RTEL1, a helicase with critical telomeric functions, in two families with HH. In the first family, two siblings with HH and very short telomeres inherited a premature stop codon from their mother who has short telomeres. The proband from the second family has HH and inherited a premature stop codon in RTEL1 from his father and a missense mutation from his mother, who also has short telomeres. In addition, inheritance of only the missense mutation led to very short telomeres in the proband’s brother. Targeted sequencing identified a different RTEL1 missense mutation in one additional DC proband who has bone marrow failure and short telomeres. Both missense mutations affect the helicase domain of RTEL1, and three in silico prediction algorithms suggest that they are likely deleterious. The nonsense mutations both cause truncation of the RTEL1 protein, resulting in loss of the PIP box; this may abrogate an important protein–protein interaction. These findings implicate a new telomere biology gene, RTEL1, in the etiology of DC.



We thank all of the study participants for their valuable contributions. Lisa Leathwood, RN and Maureen Risch, RN, Westat, Inc., provided excellent study support.

This study was funded by the intramural research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health and by contracts N02-CP-91026, N02-CP-11019, and HHSN261200655001C with Westat, Inc.

Supplementary material

439_2013_1265_MOESM1_ESM.pdf (14 kb)
Supplementary material 1 (PDF 13 kb)Online Resource 1: Exome coverage statistics. Exome coverage, off-target and on-target bases are indicated for two DC families
439_2013_1265_MOESM2_ESM.pdf (15 kb)
Supplementary material 2 (PDF 15 kb)Online Resource 2: Exome variant filtering strategy. Variants were sequentially filtered by the criteria described
439_2013_1265_MOESM3_ESM.pdf (29 kb)
Supplementary material 3 (PDF 29 kb)Online Resource 3: Variants found in RTEL1 by targeted sequencing. Targeted sequencing of RTEL1 exons revealed variants that were common (MAF > 1 %), synonymous, or predicted to be benign
439_2013_1265_MOESM4_ESM.pdf (15 kb)
Supplementary material 4 (PDF 15 kb)Online Resource 4: Primers for the RTEL1 locus used in IonTorrent sequencing. These primers were used for targeted sequencing of the RTEL1 exons


  1. 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467:1061–1073. doi: 10.1038/nature09534 CrossRefGoogle Scholar
  2. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249. doi: 10.1038/nmeth0410-248 PubMedCrossRefGoogle Scholar
  3. Alter BP, Giri N, Savage SA, Rosenberg PS (2009) Cancer in dyskeratosis congenita. Blood 113:6549–6557. doi: 10.1182/blood-2008-12-192880 PubMedCrossRefGoogle Scholar
  4. Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS (2010) Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 150:179–188. doi: 10.1111/j.1365-2141.2010.08212.x PubMedGoogle Scholar
  5. Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA (2012) Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 97:353–359. doi: 10.3324/haematol.2011.055269 PubMedCrossRefGoogle Scholar
  6. Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW (2005) Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA 102:15960–15964. doi: 10.1073/pnas.0508124102 PubMedCrossRefGoogle Scholar
  7. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM (2006) Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 1:2365–2376. doi: 10.1038/nprot.2006.263 PubMedCrossRefGoogle Scholar
  8. Binkley J, Karra K, Kirby A, Hosobuchi M, Stone EA, Sidow A (2010) ProPhylER: a curated online resource for protein function and structure based on evolutionary constraint analyses. Genome Res 20:142–154. doi: 10.1101/gr.097121.109 PubMedCrossRefGoogle Scholar
  9. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43:491–498. doi: 10.1038/ng.806 PubMedCrossRefGoogle Scholar
  10. Ding H, Schertzer M, Wu X, Gertsenstein M, Selig S, Kammori M, Pourvali R, Poon S, Vulto I, Chavez E, Tam PP, Nagy A, Lansdorp PM (2004) Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 117:873–886. doi: 10.1016/j.cell.2004.05.026 PubMedCrossRefGoogle Scholar
  11. Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y (2011) Cancer susceptibility variants and the risk of adult glioma in a US case–control study. J Neurooncol 104:535–542. doi: 10.1007/s11060-010-0506-0 PubMedCrossRefGoogle Scholar
  12. Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, Proytcheva M, German J (1995) The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell 83:655–666PubMedCrossRefGoogle Scholar
  13. Glusman G, Caballero J, Mauldin DE, Hood L, Roach JC (2011) Kaviar: an accessible system for testing SNV novelty. Bioinformatics 27:3216–3217. doi: 10.1093/bioinformatics/btr540 PubMedCrossRefGoogle Scholar
  14. Gonzalez-Perez A, Lopez-Bigas N (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 88:440–449. doi: 10.1016/j.ajhg.2011.03.004 PubMedCrossRefGoogle Scholar
  15. Keller RB, Gagne KE, Usmani GN, Asdourian GK, Williams DA, Hofmann I, Agarwal S (2012) CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer 59:311–314. doi: 10.1002/pbc.24193 PubMedCrossRefGoogle Scholar
  16. Kitao S, Shimamoto A, Goto M, Miller RW, Smithson WA, Lindor NM, Furuichi Y (1999) Mutations in RECQL4 cause a subset of cases of Rothmund–Thomson syndrome. Nat Genet 22:82–84. doi: 10.1038/8788 PubMedCrossRefGoogle Scholar
  17. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081. doi: 10.1038/nprot.2009.86 PubMedCrossRefGoogle Scholar
  18. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, Arwert F, Mathew CG, Zdzienicka MZ, Hiom K, De Winter JP, Joenje H (2005) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J. Nat Genet 37:934–935. doi: 10.1038/ng1625 CrossRefGoogle Scholar
  19. Marrone A, Walne A, Tamary H, Masunari Y, Kirwan M, Beswick R, Vulliamy T, Dokal I (2007) Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood 110:4198–4205. doi: 10.1182/blood-2006-12-062851 PubMedCrossRefGoogle Scholar
  20. Nelson ND, Bertuch AA (2012) Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res 730:43–51. doi: 10.1016/j.mrfmmm.2011.06.008 PubMedCrossRefGoogle Scholar
  21. Notredame C, Higgins DG, Heringa J (2000) T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302:205–217. doi: 10.1006/jmbi.2000.4042 PubMedCrossRefGoogle Scholar
  22. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, Blondal T, Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Ragnarsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K, Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Matthiasdottir S, Sveinsdottir SG, Polidoro S, Hoiom V, Botella-Estrada R, Hemminki K, Rudnai P, Bishop DT, Campagna M, Kellen E, Zeegers MP, de Verdier P, Ferrer A, Isla D, Vidal MJ, Andres R, Saez B, Juberias P, Banzo J, Navarrete S, Tres A, Kan D, Lindblom A, Gurzau E, Koppova K, de Vegt F, Schalken JA, van der Heijden HF, Smit HJ, Termeer RA, Oosterwijk E, van Hooij O, Nagore E, Porru S, Steineck G, Hansson J, Buntinx F, Catalona WJ, Matullo G, Vineis P, Kiltie AE, Mayordomo JI, Kumar R, Kiemeney LA, Frigge ML, Jonsson T, Saemundsson H, Barkardottir RB, Jonsson E, Jonsson S, Olafsson JH, Gulcher JR, Masson G, Gudbjartsson DF, Kong A, Thorsteinsdottir U, Stefansson K (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41:221–227. doi: 10.1038/ng.296 PubMedCrossRefGoogle Scholar
  23. Savage SA, Bertuch AA (2010) The genetics and clinical manifestations of telomere biology disorders. Genet Med 12:753–764. doi: 10.1097GIM.0b013e3181f415b5 PubMedCrossRefGoogle Scholar
  24. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP (2008) TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 82:501–509. doi: 10.1016/j.ajhg.2007.10.004 PubMedCrossRefGoogle Scholar
  25. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308–311PubMedCrossRefGoogle Scholar
  26. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lonn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899–904. doi: 10.1038/ng.407 PubMedCrossRefGoogle Scholar
  27. Uringa EJ, Lisaingo K, Pickett HA, Brind’amour J, Rohde JH, Zelensky A, Essers J, Lansdorp PM (2012) RTEL1 contributes to DNA replication and repair and telomere maintenance. Mol Biol Cell 23:2782–2792. doi: 10.1091/mbc.E12-03-0179 PubMedCrossRefGoogle Scholar
  28. Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, Ding H, Boulton SJ (2012) RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149:795–806. doi: 10.1016/j.cell.2012.03.030 PubMedCrossRefGoogle Scholar
  29. Verdun RE, Karlseder J (2006) The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127:709–720. doi: 10.1016/j.cell.2006.09.034 PubMedCrossRefGoogle Scholar
  30. Vulliamy TJ, Dokal I (2008) Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie 90:122–130. doi: 10.1016/j.biochi.2007.07.017 PubMedCrossRefGoogle Scholar
  31. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36:447–449. doi: 10.1038/ng1346 PubMedCrossRefGoogle Scholar
  32. Wallace IM, O’Sullivan O, Higgins DG, Notredame C (2006) M-Coffee: combining multiple sequence alignment methods with T-Coffee. Nucleic Acids Res 34:1692–1699. doi: 10.1093/nar/gkl091 PubMedCrossRefGoogle Scholar
  33. Walne A, Bhagat T, Kirwan M, Gitaux C, Desguerre I, Leonard N, Nogales E, Vulliamy T, Dokal I (2012) Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica. doi: 10.3324/haematol.2012.071068 Google Scholar
  34. Wang RC, Smogorzewska A, de Lange T (2004) Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119:355–368. doi: 10.1016/j.cell.2004.10.011 PubMedCrossRefGoogle Scholar
  35. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ (2009) Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189–1191. doi: 10.1093/bioinformatics/btp033 PubMedCrossRefGoogle Scholar
  36. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, Kollmeyer TM, Kosel ML, LaChance DH, McCoy L, O’Neill BP, Patoka J, Pico AR, Prados M, Quesenberry C, Rice T, Rynearson AL, Smirnov I, Tihan T, Wiemels J, Yang P, Wiencke JK (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905–908. doi: 10.1038/ng.408 PubMedCrossRefGoogle Scholar
  37. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD (1996) Positional cloning of the Werner’s syndrome gene. Science 272:258–262PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg (outside the USA) 2013

Authors and Affiliations

  • Bari J. Ballew
    • 1
  • Meredith Yeager
    • 2
  • Kevin Jacobs
    • 2
  • Neelam Giri
    • 1
  • Joseph Boland
    • 2
  • Laurie Burdett
    • 2
  • Blanche P. Alter
    • 1
  • Sharon A. Savage
    • 1
  1. 1.Clinical Genetics Branch, Division of Cancer Epidemiology and GeneticsNational Cancer InstituteRockvilleUSA
  2. 2.Cancer Genomics Research LaboratoryFrederickUSA

Personalised recommendations